Texas put $3 billion on the table to prove it was serious about fighting cancer. But convincing scientists that's still the case will take more than money.
Hundreds of the nation's top cancer researchers will be looking for answers and reassurance this week from the Cancer Prevention and Research Institute of Texas. The agency's annual conference begins Wednesday in Austin.
The agency is the nation's second-biggest pot of cancer research dollars. But the agency is reeling amid high-profile resignations and accusations of political influence. Almost three dozen scientists, including a Nobel laureate, resigned just this month.
Nearly 900 scientists and agency stakeholders are expected to attend this week's conference. The keynote speaker is Dr. Brian Druker, the celebrated oncologist who developed the groundbreaking cancer drug Gleevec.
